Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma
Open Access
- 29 June 2010
- Vol. 116 (19) , 4632-4637
- https://doi.org/10.1002/cncr.25405
Abstract
BACKGROUND: Brain tissue obtained at autopsy has been used in research for non‐oncologic disorders. However, to the best of the authors' knowledge, this tool has never been systematically used in large investigational studies for cancer. A prospective, multicenter study was conducted to assess the feasibility of tissue collection at autopsy and its suitability for molecular analyses in children with diffuse intrinsic pontine glioma. METHODS: Tumor tissue was collected at the time of diagnosis, if clinically indicated, or at autopsy. Normal brain tissue was also collected at autopsy. The integrity of DNA and RNA was evaluated in all samples. Logistic data regarding autopsies were recorded. The feasibility of tissue collection at autopsy was assessed for patients treated at a single institution over a 43‐month period. RESULTS: Tumor samples were collected at the time of diagnosis (n = 3) or at autopsy (n = 38) at 29 centers across the United States; samples were obtained at diagnosis and autopsy in 2 cases. The median interval from death to autopsy was 7.7 hours. DNA and RNA with minimal or partial degradation, which were suitable for genome‐wide analysis, were obtained from 100% and 63% of tumor samples, respectively. At the coordinating institution, approximately 40% of parents consented to autopsy and 40% declined. During the study period, 12 autopsies were performed on patients who did not receive therapy at the coordinating center. CONCLUSIONS: Multicenter, biological studies based on tissue obtained at autopsy appear to be feasible in children with brain cancer. The current experience established a new paradigm for brain tissue collection, which may increase the potential for research studies in patients with cancer. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 28 references indexed in Scilit:
- Brainstem Serotonergic Deficiency in Sudden Infant Death SyndromeJAMA, 2010
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1Cancer Cell, 2010
- Different molecular patterns in glioblastoma multiforme subtypes upon recurrenceJournal of Neuro-Oncology, 2009
- MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide ResistanceClinical Cancer Research, 2009
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Identification of interleukin-13 receptor α2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem gliomaNeuro-Oncology, 2008
- Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomasJournal of Neuro-Oncology, 2008
- EWS/FLI-1 Induces Rapid Onset of Myeloid/Erythroid Leukemia in MiceMolecular and Cellular Biology, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004